维普中文期刊产品整合服务
18篇 您的检索式:作者名="Sevastianos"
    题名 作者 年代 出处 被引量
1MELD vs Child-Pugh and creatinine-modified Child-Pugh score for Dredicting survival in patients with decompensated cirrhosis显示文摘AIM: Model of End-stage Liver Disease (MELD) score has recently gained wide acceptance over the old Child-Pugh score in predicting survival in patients with decompensated cirrhosis, although it is more sophisticated. We compared the predictive values of MELD, Child-Pugh and creatinine modified Child-Pugh scores in decompensated cirrhosis. METHODS: A cohort of 102 patients with decompensated cirrhosis followed-up for a median of 6 mo was studied.Two types of modified Child-Pugh scores estimated by adding 0-4 points to the original score using creatinine levels as a sixth categorical variable were evaluated.RESULTS: The areas under the receiver operating characteristic curves did not differ significantly among the four scores, but none had excellent diagnostic accuracy (areas:0.71-0.79). Child-Pugh score appeared to be the worst, while the accuracy of MELD was almost identical with that of modified Child-Pugh in predicting short-term and slightly better in predicting medium-term survival. In Cox regression analysis, all four scores were significantly associated with survival, while MELD and creatinine-modified Child-Pugh scores had better predictive values (c-statistics: 0.73 and 0.69-0.70) than Child-Pugh score (c-statistics: 0.65). Adjustment for gamma-glutamate transpeptidase levels increased the predictive values of all systems (c-statistics: 0.77-0.81). Analysis of the expected and observed survival curves in patients subgroups according to their prognosis showed that all models fit the data reasonably well with MELD probably discriminating better the subgroups with worse prognosis. CONCLUSION: MELD compared to the old Child-Pugh and particularly to creatinine-modified Child-Pugh scores does not appear to offer a clear advantage in predicting survival in patients with decompensated cirrhosis in daily clinical practice.George V. Papatheodoridis Evangelos Cholongitas Eleni Dimitriadou Giota Touloumi Vassilios Sevastianos Athanasios J. Archimandritis 2005World Journal of Gastroenterology2005,11,20:30
2Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir显示文摘Stephanos J. Hadziyannis Vassilios Sevastianos Irene Rapti Dimitrios Vassilopoulos Emilia Hadziyannis 2012Gastroenterology2012,,3:2
3Pegylatied interferon-2b-associated autoimmue thrombocytopenia in a patient with chronic hepatitis C显示文摘Sevastianos VA Deutsch M Dourakis SP 2003Am J Gastroenterol2003,98,3:1
4Development of a bionematicide with Paecilomyces lilacinus to control Meloidogyne incognita显示文摘Band Debora Roussos Sevastianos Pandey Ashok 2004Applied Biochemistry and Biotechnology2004,118,13:1
5Nonalcoholic fatty liver disease: from cliuieal recognition to treatment 显示文摘Sevastianos VA Hadziyannis SJ 2008Expert Rev Gastroenterol Hepatol2008,2,1:1
6Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection显示文摘Manesis EK Papatheodoridis GV Sevastianos V 0,,10:1
7Water and water activity in the solid state fermentation of cassava starch by Aspergillus niger显示文摘Eric Oriol Maurice Raimbault Sevastianos Roussos 1988Applied Microbiology Biotechnology1988,27,:1
8Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era显示文摘Papatheodoridis GV Sevastianos V Burroughs AK 2003Am J Transplant2003,3,3:1
9Nonalcoholic fatty liver disease:from clinical recognition to treatment显示文摘Sevastianos VA Hadziyannis SJ 2008Expert Rev Gastroenterol Hepatol2008,2,1:1
10Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long- term treatment with adefovir显示文摘Hadziyannis SJ Sevastianos V Rapti I 2012Gastroenterolog)52012,143,3:1
11Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era显示文摘Papatheodoridis GV Sevastianos V Burroughs AK 2003Am J Transplant2003,3,:1
12Significance of hepatitis B viremia levels, determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection显示文摘Manesis E K Papatheodoridis G V Sevastianos V 2003Am J Gastroenterol2003,98,10:1
13Nonalcoholic fatty liver disease:from clinical recognition to treatment显示文摘Sevastianos VA Hadziyannis SJ 2008Expert Rev Gastroenterol Hepatol2008,2,1:1
14Mitigating COs emissions from energy use in the world's bulidings 显示文摘DIANAURGE-VORSATZ DANNY HARVEY SEVASTIANOS MIRASGEDIS 2007Building Research & Information2007,35,4:1
15Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir显示文摘Hadziyannis SJ Sevastianos V Rapti I 2012Gastroenterology2012,143,3:1
16Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chro- nic hepatitis B virus infection 显示文摘Manesis EK Papatheodoridis GV Sevastianos V 2003Am J Gastroenterol2003,98,10:1
17Sus-tained responses and loss of HBsAg in HBeAg - negative pa-tients with chronic hepatitis B who stop long - term treat-ment with adefovir显示文摘HADZIYANNIS SJ SEVASTIANOS V RAPTI I 2012Gastroenterology2012,143,3:1
18Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen–negative chronic hepatitis B virus infection显示文摘Emanuel K Manesis George V Papatheodoridis Vasilios Sevastianos Evangelos Cholongitas Christos Papaioannou Stephanos J Hadziyannis 2003The American Journal of Gastroenterology2003,,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费